Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2021
Dec. 31, 2020
CURRENT ASSETS    
Cash $ 81,373,725 $ 19,229,232
Prepaid expenses and other current assets 1,110,770 1,007,690
Total current assets 82,484,495 20,236,922
Property and equipment, net 20,164 21,507
Deferred offering costs 101,205
TOTAL ASSETS 82,504,659 20,359,634
CURRENT LIABILITIES    
Accounts payable and accrued expenses 664,533 552,339
Total current liabilities 664,533 552,339
PPP loan payable 108,500 108,500
TOTAL LIABILITIES 773,033 660,839
COMMITMENTS AND CONTINGENCIES (NOTE 4)
STOCKHOLDERS’ EQUITY    
Preferred Stock - Par Value (1,000,000 authorized at March 31, 2021 and December 31, 2020; $.0001 par value) (Zero shares issued and outstanding at March 31, 2021 and December 31, 2020)
Common Stock – Par Value (25,000,000 authorized at March 31, 2021 and December 31, 2020; $.0001 par value) (11,181,447 shares issued and outstanding at March 31, 2021; 6,220,927 shares issued and outstanding at December 31, 2020) 1,118 622
Additional paid-in capital 96,842,698 32,358,068
Accumulated deficit (15,112,190) (12,659,895)
Total stockholders’ equity 81,731,626 19,698,795
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 82,504,659 $ 20,359,634